MENU
VRTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vertex Pharmaceuticals (VRTX) Earnings Date & Reports

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

VRTX is expected to report earnings to rise 6.46% to $5.11 per share on February 04

Vertex Pharmaceuticals VRTX Stock Earnings Reports
Q4'25
Est.
$5.11
Q3'25
Beat
by $0.23
Q2'25
Beat
by $0.25
Q1'25
Missed
by $0.20
Q4'24
Missed
by $0.04
The last earnings report on November 03 showed earnings per share of $4.80, beating the estimate of $4.57. With 1.56M shares outstanding, the current market capitalization sits at 110.25B.
View a ticker or compare two or three
VRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VRTX showed earnings on November 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a company that discovers and develops novel, small molecule pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
50 Northern Avenue
Phone
+1 617 341-6100
Employees
5400
Web
https://www.vrtx.com